Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,565 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06753331RecruitingPhase 1/Phase 2
Study of DSP-1083 for Parkinson's disease
This trial tests a new treatment called DSP-1083 for people with Parkinson's disease whose symptoms are not well controlled with standard medications. The study will check if it is safe and if it helps improve movement and daily function.
La Jolla, CaliforniaAges 40–72 - NCT07184944RecruitingPhase 3
Study of Duvakitug for moderate to severe Crohn's disease
This study tests a new drug called duvakitug to see if it can help maintain improvement in people with moderate to severe Crohn's disease. It's for patients who have already responded to treatment in a previous study.
Colorado Springs, ColoradoAges 16–80 - NCT07882121Recruiting
Mesh shaping for broken eye socket repair
This trial tests two ways of shaping a mesh used to fix a broken bone around the eye. One method uses a 3D model made from your own scan, and the other is done by hand during surgery. It aims to see which gives better results for eye position and movement.
Cairo, AbbasiaAges 18–55 - NCT07882108Recruiting
Ginger for stomach and appetite problems in Parkinson's
This trial tests whether ginger can improve stomach function and appetite in people with Parkinson's disease. It aims to see if ginger affects ghrelin, a hormone that helps regulate hunger, which may help with gut issues and weight loss common in PD.
CambridgeAges 55 years+ - NCT07884045Recruiting
Cutting ultra-processed food to lengthen remission in kids with Crohn's
This study looks at whether cutting down on ultra-processed foods (like packaged snacks and sugary drinks) can help keep Crohn's disease in remission longer in children and teens. Participants will get guidance on a healthier eating plan.
PragueAges 10–18 - NCT07884227Recruiting
Genetic testing to find causes of autism and intellectual disability
This study uses advanced genetic testing to try to find the cause of autism or other developmental disorders in people with severe intellectual disability. It may help provide answers for families who have not gotten a clear genetic diagnosis from previous testing.
GenovaAges Any age - NCT04374721Recruiting
Circadian rhythm genes in adrenal and cortisol disorders
This study looks at how your body's internal clock genes may be affected by adrenal problems or Cushing's syndrome, and how they might change with treatment. It aims to better understand these conditions and potentially improve care.
Roma, RomaAges 18–80 - NCT04774536RecruitingPhase 1/Phase 2
CRISPR gene-edited bone marrow transplant for severe sickle cell
This Phase 1/2 study tests a CRISPR-edited bone marrow (stem cell) transplant to treat severe sickle cell disease. It aims to reduce dangerous sickle-related complications by changing the patient’s stem cells before transplant.
Davis, CaliforniaAges 12–35 - NCT07190196RecruitingPhase 3
Study of Rilzabrutinib for IgG4-related disease
This trial tests a medication called rilzabrutinib to see if it can safely control IgG4-related disease (a condition causing inflammation in various organs) better than a placebo. It may help you reduce or stop your current steroid treatment.
Fontana, CaliforniaAges 18 years+ - NCT07141628Recruiting
Lipoprotein(a) and heart risk in stage 4 kidney disease
This study looks at whether a fat in your blood called lipoprotein(a) can help predict heart problems in people with stage 4 kidney disease. By tracking your health over 18 months, doctors hope to find better ways to protect your heart.
NîmesAges 18–80 - NCT07053423RecruitingPhase 4
Dupilumab for COPD with airway inflammation
This study tests if a drug called dupilumab, given as a shot under the skin, can reduce airway inflammation in people aged 40-85 with moderate-to-severe COPD who also have signs of a specific type of inflammation called Type 2. It may help if you have frequent flare-ups and are already using multiple inhalers.
Birmingham, AlabamaAges 40–85 - NCT07822334RecruitingPhase 1/Phase 2
Study of an investigational drug for chronic obstructive pulmonary disease
This study tests an experimental medication for chronic obstructive pulmonary disease (COPD) in two parts: first in healthy volunteers, then in people with COPD. It aims to see if the drug is safe and how well it works.
Wythenshawe, Greater ManchesterAges 18–80 - NCT07697456RecruitingPhase 2
Study of advanced therapies for Crohn's or ulcerative colitis
This study tests advanced treatments for people with moderate to severe Crohn's disease or ulcerative colitis who haven't responded to at least one previous therapy. It aims to find better options for managing these conditions.
Dothan, AlabamaAges 18–75 - NCT07611578Recruiting
Dual task training for confidence in Parkinson's disease
This study tests a training program that combines physical tasks with thinking challenges (dual tasking). It may help people with Parkinson's feel more confident in their daily activities and improve their quality of life.
Santiago, Las CondesAges 18 years+ - NCT05003947RecruitingPhase 1
Stem cell infusion for Crohn’s or ulcerative colitis safety
This Phase 1 trial tests whether an IV infusion of donated (allogeneic) stem cells is safe in people with Crohn’s disease or ulcerative colitis. It focuses mainly on safety and tolerability, and it may offer a new treatment approach if you qualify.
Naples, FloridaAges Any age - NCT07875088Recruiting
Drug-coated balloons for coronary artery disease
This study looks at how well drug-coated balloons work in real life for people with coronary artery disease. These balloons deliver medicine to open blocked heart arteries, and this trial aims to see how they perform in different patients.
Mexico City, Mexico CityAges 18 years+ - NCT06831032Recruiting
Adaptive radiation for prostate cancer in lymph nodes
This trial tests a type of targeted radiation (SBRT) for prostate cancer that has come back only in certain lymph nodes around the belly or hip. The goal is to see if adapting the radiation plan during treatment can make the response last longer.
Toronto, OntarioAges 18 years+ - NCT03394365RecruitingPhase 3
Study of tabelecleucel for transplant patients with EBV-related lymphoma
This trial tests an investigational treatment called tabelecleucel for people who developed a type of lymphoma after an organ or stem cell transplant. The lymphoma is caused by the Epstein-Barr virus (EBV) and has not responded to standard therapy with rituximab or chemotherapy. Tabelecleucel uses special immune cells to fight the virus and the cancer.
Duarte, CaliforniaAges Any age - NCT07880275Recruiting
Memory disorders research study
This study collects health information and samples from people with memory problems and from healthy younger adults to better understand memory disorders. Participating may help researchers learn more about these conditions.
Seoul, Seodamun-guAges 19 years+ - NCT07880379RecruitingPhase 1
Brain scan for Parkinson's disease
This trial tests a new brain scan that may show a protein linked to Parkinson's disease. It could help doctors see the disease better and might lead to earlier diagnosis and better treatment.
New Haven, ConnecticutAges 40–80 - NCT07881627Recruiting
Amino acid nutrition during dialysis for malnutrition and anemia
This trial is testing whether giving a special amino acid solution during dialysis can improve nutrition in people with kidney disease who are on dialysis and also have malnutrition and anemia. Amino acids are the building blocks of protein, and this may help you gain strength and improve your overall health.
Bangli, BaliAges 18 years+ - NCT05757141RecruitingPhase 1/Phase 2
Fosigotifator study for vanishing white matter disease
This study tests an investigational drug called fosigotifator for people with vanishing white matter disease. It aims to see if the drug can help slow down or improve symptoms, and it is open to children, teens, and adults with a confirmed diagnosis.
Boston, MassachusettsAges 6 months+ - NCT07641556Recruiting
Remote training for arm movement in Parkinson's disease
This study tests whether doing arm-coordination exercises remotely (via video call) with dual tasks—like moving your arms while counting—can help improve hand function in people with Parkinson's disease. You'd do sessions at home with a caregiver's help.
AnkaraAges 40 years+ - NCT07177352RecruitingPhase 3
Screening for Roche Alzheimer's studies
This is a screening study to find people who might be eligible for other Alzheimer's drug studies run by the same company. It helps match you to a treatment trial if you qualify.
Birmingham, AlabamaAges 50–90
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,565 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.